Lilayi Medical Limited 14753946 false 2024-04-01 2025-03-31 2025-03-31 The principal activity of the company is is that of the provision of specialist healthcare services. Digita Accounts Production Advanced 6.30.9574.0 true 14753946 2024-04-01 2025-03-31 14753946 2025-03-31 14753946 bus:Director1 1 2025-03-31 14753946 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 14753946 bus:Micro-entities 2024-04-01 2025-03-31 14753946 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 14753946 bus:FilletedAccounts 2024-04-01 2025-03-31 14753946 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 14753946 bus:RegisteredOffice 2024-04-01 2025-03-31 14753946 bus:Director1 2024-04-01 2025-03-31 14753946 bus:Director1 1 2024-04-01 2025-03-31 14753946 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 14753946 bus:Agent1 2024-04-01 2025-03-31 14753946 countries:AllCountries 2024-04-01 2025-03-31 14753946 bus:Director1 1 2024-03-31 14753946 2023-03-24 2024-03-31 14753946 2024-03-31 14753946 bus:Director1 1 2024-03-31 14753946 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 14753946 bus:Director1 1 2023-03-24 2024-03-31 14753946 bus:Director1 1 2023-03-23 iso4217:GBP xbrli:pure

Registration number: 14753946

Lilayi Medical Limited
Unaudited Filleted Financial Statements
for the Year Ended 31 March 2025

Lilayi Medical Limited

Contents

Company Information | 1
Director's Report | 2
Balance Sheet | 3 to 4
Notes to the Unaudited Financial Statements | 3

Lilayi Medical Limited

Company Information

Director | Mr Henry Sibenge

Registered office | 1D Calthorpe Mansions Calthorpe Road Edgbaston Birmingham B15 1QS

Accountants | Upton & Co Accountants Limited Chartered Certified Accountants182 Pontefract Road Cudworth Barnsley South Yorkshire S72 8BE

Lilayi Medical Limited

Director's Report for the Year Ended 31 March 2025

The director presents his report and the financial statements for the year ended 31 March 2025.
This report has been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and in accordance with FRS 105 The Financial Reporting Standard applicable to the Micro-entities Regime.

Director of the company

The director who held office during the year was as follows:

Mr Henry Sibenge

Small companies provision statement

This report has been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

Approved and authorised by the director on 5 March 2026

......................................... Mr Henry Sibenge Director

Lilayi Medical Limited

(Registration number: 14753946)
Balance Sheet as at 31 March 2025

| 2025 £ | 2024 £
Current assets | 15,926 | 9,789
Creditors: Amounts falling due within one year | (13,505) | (7,993)
Total assets less current liabilities | 2,421 | 1,796
Accruals and deferred income | (1,380) | (720)
| 1,041 | 1,076
Capital and reserves | 1,041 | 1,076

1 | General information

The company is a private company limited by share capital, incorporated in England & Wales.

The address of its registered office is:
1D Calthorpe Mansions
Calthorpe Road
Edgbaston
Birmingham
B15 1QS

These financial statements were authorised for issue by the director on 5 March 2026.

2 | Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2024 - 1).

3 | Related party transactions

Transactions with the director

2025 | At 1 April 2024 £ | Advances to director £ | At 31 March 2025 £
Mr Henry Sibenge
DLA | 7,232 | 7,644 | 14,876

2024 | At 24 March 2023 £ | Advances to director £ | At 31 March 2024 £
Mr Henry Sibenge
DLA | - | 7,232 | 7,232

Lilayi Medical Limited

(Registration number: 14753946)
Balance Sheet as at 31 March 2025

For the financial year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
• | The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the micro entities regime and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 5 March 2026

......................................... Mr Henry Sibenge Director